Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
by
Mollo, Nunzia
, Sarnataro, Viviana
, Conti, Anna
, Bonfiglio, Ferdinando
, Nitsch, Lucio
, Cicatiello, Rita
, Paladino, Simona
, Barbato, Maria
, Izzo, Antonella
, Genesio, Rita
, Nitti, Maria
, Calì, Gaetano
in
Animals
/ Biomedical and Life Sciences
/ Biomedicine
/ Biosynthesis
/ Brain
/ Chromosome 21 genes
/ Down syndrome
/ Down Syndrome - genetics
/ Down Syndrome - metabolism
/ Down syndrome therapy
/ Down syndrome/trisomy of chromosome 21
/ Energy conversion
/ Fetuses
/ Fibroblasts
/ Gene expression
/ Genotype & phenotype
/ Heart
/ Humans
/ Kinases
/ Lipids
/ Metabolism
/ Mitochondria
/ Mitochondria - metabolism
/ Mitochondrial DNA
/ Mitochondrial dynamics
/ Mitochondrial dysfunction
/ Molecular Medicine
/ Morphology
/ Oxidation
/ Oxidative stress
/ Proteins
/ Review
/ Transcription factors
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
by
Mollo, Nunzia
, Sarnataro, Viviana
, Conti, Anna
, Bonfiglio, Ferdinando
, Nitsch, Lucio
, Cicatiello, Rita
, Paladino, Simona
, Barbato, Maria
, Izzo, Antonella
, Genesio, Rita
, Nitti, Maria
, Calì, Gaetano
in
Animals
/ Biomedical and Life Sciences
/ Biomedicine
/ Biosynthesis
/ Brain
/ Chromosome 21 genes
/ Down syndrome
/ Down Syndrome - genetics
/ Down Syndrome - metabolism
/ Down syndrome therapy
/ Down syndrome/trisomy of chromosome 21
/ Energy conversion
/ Fetuses
/ Fibroblasts
/ Gene expression
/ Genotype & phenotype
/ Heart
/ Humans
/ Kinases
/ Lipids
/ Metabolism
/ Mitochondria
/ Mitochondria - metabolism
/ Mitochondrial DNA
/ Mitochondrial dynamics
/ Mitochondrial dysfunction
/ Molecular Medicine
/ Morphology
/ Oxidation
/ Oxidative stress
/ Proteins
/ Review
/ Transcription factors
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
by
Mollo, Nunzia
, Sarnataro, Viviana
, Conti, Anna
, Bonfiglio, Ferdinando
, Nitsch, Lucio
, Cicatiello, Rita
, Paladino, Simona
, Barbato, Maria
, Izzo, Antonella
, Genesio, Rita
, Nitti, Maria
, Calì, Gaetano
in
Animals
/ Biomedical and Life Sciences
/ Biomedicine
/ Biosynthesis
/ Brain
/ Chromosome 21 genes
/ Down syndrome
/ Down Syndrome - genetics
/ Down Syndrome - metabolism
/ Down syndrome therapy
/ Down syndrome/trisomy of chromosome 21
/ Energy conversion
/ Fetuses
/ Fibroblasts
/ Gene expression
/ Genotype & phenotype
/ Heart
/ Humans
/ Kinases
/ Lipids
/ Metabolism
/ Mitochondria
/ Mitochondria - metabolism
/ Mitochondrial DNA
/ Mitochondrial dynamics
/ Mitochondrial dysfunction
/ Molecular Medicine
/ Morphology
/ Oxidation
/ Oxidative stress
/ Proteins
/ Review
/ Transcription factors
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
Journal Article
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
2018
Request Book From Autostore
and Choose the Collection Method
Overview
Trisomy of chromosome 21 (TS21) is the most common autosomal aneuploidy compatible with postnatal survival with a prevalence of 1 in 700 newborns. Its phenotype is highly complex with constant features, such as mental retardation, dysmorphic traits and hypotonia, and variable features including heart defects, susceptibility to Alzheimer’s disease (AD), type 2 diabetes, obesity and immune disorders. Overexpression of genes on chromosome-21 (Hsa21) is responsible for the pathogenesis of Down syndrome (DS) phenotypic features either in a direct or in an indirect manner since many Hsa21 genes can affect the expression of other genes mapping to different chromosomes. Many of these genes are involved in mitochondrial function and energy conversion, and play a central role in the mitochondrial dysfunction and chronic oxidative stress, consistently observed in DS subjects.
Recent studies highlight the deep interconnections between mitochondrial dysfunction and DS phenotype. In this short review we first provide a basic overview of mitochondrial phenotype in DS cells and tissues. We then discuss how specific Hsa21 genes may be involved in determining the disruption of mitochondrial DS phenotype and biogenesis. Finally we briefly focus on drugs that affect mitochondrial function and mitochondrial network suggesting possible therapeutic approaches to improve and/or prevent some aspects of the DS phenotype.
Publisher
BioMed Central,Springer Nature B.V,BMC
Subject
/ Biomedical and Life Sciences
/ Brain
/ Down syndrome/trisomy of chromosome 21
/ Fetuses
/ Heart
/ Humans
/ Kinases
/ Lipids
/ Proteins
/ Review
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.